Vielight Neuro | Randomized Sham-Controlled EEG Neuromodulation itPBM Clinical Study (Brain Photobiomodulation)

Executive summary

A landmark study published in Scientific Reports (a Nature Portfolio journal) has confirmed that a single 20-minute session with the Vielight Neuro Gamma (810 nm NIR light pulsed at 40 Hz) induces measurable, non-invasive neuromodulation in the human brain.

Unlike previous research that focused primarily on metabolic changes, this double-blind, sham-controlled study proves that intranasal-transcranial photobiomodulation (itPBM) can actively reorganize neural oscillations and functional network connectivity in healthy older adults.

Read the full publication here: Nature

As of Aug 20, 2025, the Vielight Neuro is involved in the only high-level journal publication demonstrating EEG neuromodulation with a commercially available, wearable LED brain PBM device.

The itPBM Advantage: Integrated Delivery

The study highlights the unique efficacy of Vielight’s patented “integrated” approach of combining transcranial LEDs (targeting the cortical surface) with an intranasal emitter (targeting the ventral hubs like the ventromedial prefrontal cortex), otherwise known as itPBM. This achieves a “dual-gate” stimulation of the Default Mode Network (DMN) – the brain’s primary baseline network while maintaning a full transcranial footprint.

• Design: randomized, double-blind, sham-controlled, crossover; eyes-closed rest EEG recorded 10 min pre and 10 min post each session (active vs. sham), ≥1-week washout.

• Participants: n = 20 healthy older adults (61–74 y).

• Device: Vielight Neuro Gamma

• EEG analytics: spectral power (delta 1–3, theta 4–7, alpha 8–14, beta 14–30, gamma 30–50 Hz); functional connectivity via weighted phase-lag index (wPLI); graph-theory metrics—clustering coefficient (segregation), characteristic path length (integration), local and global efficiency.

Network Connectivity: The “Network Tune-Up”

Beyond individual waves, the study used Graph Theory to measure how information moves across the brain. itPBM induced significant changes in clustering, characteristic path length (CPL), and global efficiency.

These findings reveal that itPBM performs a “network tune-up,” making the brain more integrated and efficient. Information travels faster and more accurately across regions. Specifically, the boost in Alpha rhythms—the frequency responsible for attentional gating—helps the brain filter out irrelevant distractions, allowing for deeper engagement with complex tasks.

DMN-linked interpretation

Given the DMN-centric montage, the authors note that increases in alpha (posterior DMN) and gamma (mPFC) are consistent with literature connecting these rhythms to DMN function and attentional gating. The pattern suggests greater network organization post-stimulation.

This study provides rare evidence of “network reorganization” within the Default Mode Network (DMN)—the brain’s primary baseline network that is often the first to decline with age. By increasing Alpha and Gamma synchrony in the DMN, itPBM strengthens the brain’s ability to switch between rest and active task-processing. This improved “functional integration” is a hallmark of youthful brain function, suggesting that itPBM can help maintain the structural integrity of the brain’s communication hubs, potentially boosting long-term memory and cognitive resilience.

The Scientific Significance: Elevating itPBM as a Neuromodulation Benchmark

The findings from the Nature Scientific Reports study move photobiomodulation from a general “wellness” category into the rigorous field of clinical neuromodulation. The implications of this shift are three-fold:

1. Evidence of a Direct Mechanistic Effect

Historically, critics of PBM argued that NIR light only improved blood flow (hemodynamics) or cellular energy (metabolism). This study provides the “smoking gun” for direct neuromodulation. By demonstrating that itPBM can non-invasively alter electrical oscillations and network topology under stringent controls, it establishes itPBM as a bona fide tool for brain-tuning—comparable in mechanism to Transcranial Magnetic Stimulation (TMS) but with a significantly lower risk profile.

2. Precision Through “Temporal Coding” (The 40 Hz Factor)

The study proves that rhythmicity is a design variable. The 40 Hz (Gamma) pulse is not arbitrary; it is a “temporal code” that aligns with the brain’s internal models for inhibitory control, sensory binding, and high-level attention. This confirms that the parameterization of Vielight devices—specifically the choice of wavelength, pulse rate, and montage—creates a tractable “design space.” We can now target specific neurological outcomes by matching device parameters to the brain’s natural rhythms.

3. Moving Toward Quantitative “Network” Endpoints

Standard EEG analysis often stops at “band power” (how much Alpha or Beta is present). This study goes deeper into Network Topology—measuring clustering, path length, and efficiency.

• Why this matters: These metrics offer objective, quantitative endpoints for treatment. Instead of just aiming for “more Alpha,” practitioners can now aim to normalize DMN (Default Mode Network) dynamics. This is critical for conditions characterized by “disconnection syndromes,” such as Alzheimer’s, TBI, or depression, where the goal is to restore the brain’s structural and functional integration.

Clinical Implications: A New Era for itPBM in Neurology

The Nature Scientific Reports study is a watershed moment for integrated Transcranial-Intranasal Photobiomodulation (itPBM). It moves the technology from “supportive wellness” into the realm of “active neurological intervention.”

1. Real-Time Neuromodulation: Shifting the Cognitive State

The findings confirm that the Vielight Neuro Gamma does not merely deliver light; it actively “tunes” brain oscillations in real time.

• The Clinical Shift: By suppressing slow-wave activity (Delta/Theta) and facilitating high-frequency rhythms (Alpha, Beta, Gamma), itPBM shifts the brain from a state of lethargy or “drift” to one of active cognitive engagement.

• The “itPBM” Advantage: This dual-delivery system (transcranial + intranasal) ensures that both the cortical surfaces and deep-seated “hubs” like the ventromedial prefrontal cortex are modulated simultaneously, creating a global shift in mental clarity.

2. Restoring Network Integrity (Graph Theory Application)

The study’s focus on clustering, path length, and efficiency is highly relevant to modern neurology. These “graph-theory” metrics are the exact biomarkers that degrade in Alzheimer’s, Parkinson’s, and Traumatic Brain Injury (TBI).

• The Therapeutic Potential: If a single 20-minute session can “re-wire” a healthy aging brain toward greater integration and communication, the potential for long-term, repeated sessions to restore damaged networks in clinical populations is significant. It suggests itPBM could act as a “structural stabilizer” for the brain’s communication highways.

3. Validation of itPBM as a Peer to TMS and tDCS

Published in a Nature Portfolio journal, this research provides the high-level credibility required for mainstream medical adoption.

• A Safer Alternative: Conceptually, itPBM is now on par with Transcranial Magnetic Stimulation (TMS) and tDCS as a recognized neuromodulation modality. However, it offers a distinct advantage: it is non-invasive, low-risk, and capable of being used daily at home, bridging the gap between clinical-grade science and patient-centered care.

4. Objective Biomarkers for Precision Medicine

The study proves that EEG and connectivity changes are quantifiable, repeatable biomarkers.

• Data-Driven Treatment: For clinicians, this means the effects of itPBM are no longer subjective. We can now use EEG metrics to track a patient’s response to treatment and tailor protocols to their specific “neural signature.” This sets the foundation for closed-loop neuromodulation, where AI-driven platforms like Vie-AI can optimize parameters based on real-time brain data.

Practical Implications for Neurofeedback: A New “Neural Primer”

The study’s findings provide a roadmap for neurofeedback practitioners to integrate itPBM into their clinical workflows. By using the Vielight Neuro Gamma, practitioners can move beyond simple frequency training to more sophisticated, network-level interventions.

1. Rapid Pre-Conditioning and Actionable Biomarkers

The specific signature of ↑Alpha/Beta/Gamma and ↓Delta/Theta provides a clear “gold standard” for session efficacy.

• The Benefit: Using itPBM as a pre-conditioning tool can effectively “prime” the brain before operant training begins. By shifting the brain out of a slow-wave state and into a high-frequency state before the session starts, practitioners may significantly shorten the time required for a client to reach their training goals.

• Metric Integration: These frequency shifts serve as objective pre- and post-session metrics, allowing for a quantitative “before and after” snapshot of the patient’s neural readiness.

2. Shifting to “Network-Aware” Protocols

Most traditional neurofeedback focuses on single-electrode metrics (e.g., “reduce Theta at Cz”). This study proves that itPBM influences network-level topology, such as integration and segregation.

• The Benefit: Practitioners can now align their neurofeedback goals with network normalization. By tracking wPLI-derived connectivity and global efficiency, clinicians can ensure that the brain isn’t just producing “more Alpha,” but is actually becoming more synchronized and efficient across all hubs. This moves the practice from “location-based” training to “network-based” optimization.

3. Enhanced “Attentional Gating” for Better Training

The increase in Alpha and Gamma synchrony specifically within the Default Mode Network (DMN) is critical for “attentional gating.”

• The Benefit: A brain that can effectively gate (filter) information is a brain that can learn faster. By using itPBM to enhance this gating mechanism, clients may find it easier to enter the “flow state” required for successful neurofeedback, leading to higher engagement and better long-term retention of training gains.

Strategic Advantage for Practitioners

Conclusion: A Watershed Moment for Brain Optimization

The research published in Scientific Reports represents more than just a successful clinical trial; it is a fundamental shift in the narrative of brain wellness. By demonstrating that itPBM (integrated Transcranial-Intranasal Photobiomodulation) can measurably reorganize the human brain’s electrical landscape in a single 20-minute session, we have moved beyond the “metabolic” era of light therapy into the era of Active Neuromodulation.

For the researcher, this study provides the rigorous, peer-reviewed “benchmark” needed to elevate itPBM to the same scientific standing as TMS and tDCS. For the practitioner, it offers a new set of quantifiable biomarkers—from global efficiency to attentional gating—that can be used to optimize patient outcomes and shorten training times.

As we look toward the future, the integration of these findings into AI-driven, closed-loop systems like the Vie-AI platform promises a level of personalized neuro-optimization that was once the stuff of science fiction. Whether the goal is to combat the “drifts” of cognitive aging, recover from traumatic brain injury, or simply reach a higher state of mental performance, the science is clear: The Vielight Neuro Gamma is not just delivering light; it is tuning the very rhythm of thought.